Keyword: Servier

Drugs-2

EMA to hold major review after fatal French trial

The European Medicines Agency is to undertake a large-scale review of trial practices alongside the French drugs agency as a result of the recent disastrous trial in France which saw a study participant die. This will form the basis of a wider public consultation on the possible changes to how early-stage studies are undertaken.